Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001397331-26-000002
Filing Date
2026-03-04
Accepted
2026-03-04 16:37:44
Documents
1
Period of Report
2026-03-02

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4026
  Complete submission text file 0001397331-26-000002.txt   5729
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Issuer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 140 LASALLE AVENUE PIEDMONT CA 94610
Business Address
Williamson Robert F III (Reporting) CIK: 0001397331 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33407 | Film No.: 26722047